Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter F. Thall
Peter F. Thall
University of Michigan
Busulfan
Transplantation
Medicine
Oncology
Internal medicine
3
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
2018
Bone Marrow Transplantation
Gheath Alatrash
Kelly M. Kidwell
Peter F. Thall
Antonio Di Stasi
Julianne Chen
Madhushree Zope
Alyssa K. Crain
Richard E Champlin
Uday R Popat
Elizabeth J. Shpall
Roy B. Jones
Borje S Andersson
Show All
Source
Cite
Save
Citations (6)
Multi-institutional study of allogeneic bone marrow transplantation using myeloablative busulfan (Bu)/fludarabine (Flu) conditioning and short-course, single-agent graft-versus-host disease (GVHD) prophylaxis with high-dose, post-transplantation cyclophosphamide (PTCy).
2013
Journal of Clinical Oncology
Christopher G. Kanakry
Paul V. ODonnell
Marcos de Lima
Wei Wei
Terry Furlong
Marta Medeot
Richard J. Jones
Peter F. Thall
Borje S Andersson
Leo Luznik
Show All
Source
Cite
Save
Citations (1)
Transplantation of Cord Blood Expanded Ex Vivo with Copper Chelator.
2004
Blood
E. Shpall
M. de Lima
K.W Chan
Richard E Champlin
Adrian P. Gee
Peter F. Thall
Krishna V. Komanduri
Daniel R. Couriel
B. Andersson
Chitra Hosing
Sergio Giralt
S. Karandish
Tara Sadeghi
B. Muriera
Tony Peled
Frida Grynspan
A. Nagler
John McMannis
Show All
Source
Cite
Save
Citations (3)
1